Analysis of their data showed that dramatic responses obtained in multiple syngeneic tumor models were due to restoring CD8+ T-cell activity when bsAbs were targeting PD-L1 in the membrane of DCs, inhibiting negative regulation and enhancing the stimulation via cytokines and co-stimulatory molecules. The gene discussed is CD274; the disease is neoplasm.